iTeos Therapeutics
Biotechnology ResearchView the employees at
iTeos Therapeutics-
Philippe Brantegem Executive Vice President, Human Resources chez iTeos Therapeutics
-
Brussels Region, Belgium
-
Top 5%
Noémie Wald Tissue Biomarker Lead in immuno-oncology drug discovery, Ph. D.-
Brussels Metropolitan Area
-
Rising Star
jennifer johnston Head of ClinOps Center of Excellence, iTeos-
Saddle River, New Jersey, United States
-
Top 5%
Overview
iTeos Therapeutics is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients. iTeos Therapeutics leverages its deep understanding of tumor immunology and immunosuppressive pathways to design novel product candidates with the potential to restore the immune response against cancer. The Company’s innovative pipeline includes three clinical-stage programs targeting novel, validated immuno-oncology pathways designed with optimized pharmacologic properties for improved clinical outcomes, including the TIGIT:CD226 axis and the adenosine pathway. iTeos Therapeutics is headquartered in Watertown, MA with a research center in Gosselies, Belgium.
-